Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (1) | Back to Search
Waste of oral oncolytics and biologicals among users who discontinue therapy
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-E-005-Tuesday
- By: BEKKER, Charlotte (Sint Maartenskliniek, Pharmacy, Nijmegen, Netherlands)
- Co-author(s): Charlotte Bekker: Pharmacy, Sint Maartenskliniek, Nijmegen, Netherlands;Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands
Helga Gardarsdottir: Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands;Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands
Eward Melis: Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands
Toine Egberts: Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands;Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands
Marcel Bouvy: Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands
Bart van den Bemt: Pharmacy, Sint Maartenskliniek, Nijmegen, Netherlands;Pharmacy, Radboud University Medical Centre, Nijmegen, Netherlands - Abstract:
Backgrounds
Oral oncolytics and biological DMARDs (bDMARDs) are costly therapies. If patients stop their therapy it may lead to medication waste if drugs are taken from the pharmacy but left unused.Aims
We examined the proportion oral oncolytics and bDMARDs users who stop their therapy and have drugs leftover, the related costs, and the proportion.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023